Biotech stocks hit a post-pandemic high on Moderna trial win
· seekingalpha.com
Biotech stocks hit a post-pandemic high after a late-stage trial win for Moderna (MRNA) and Merck's (MRN) mRNA-based cancer vaccine. Read more here.
Biotech stocks have reached their highest level since the height of the pandemic after Moderna (MRNA) and Merck (MRK) announced that a late-stage trial testing ...